Our work implies organ-specific mechanisms by which myeloid cells regulate angiogenesis because myeloid cells do provide a significant and nonredundant source of vascular endothelial growth factor to promote pathological angiogenesis in other settings, such as skin wound healing and cancer. This evidence concerns the gene VEGFA and cancer.